NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is P73398102. A total of 47 filers reported holding NYMOX PHARMACEUTICAL CORP in Q1 2018. The put-call ratio across all filers is 4.69 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $53,000 | -64.4% | 33,665 | -49.7% | 0.00% | – |
| Q1 2021 | $149,000 | +10.4% | 66,985 | +22.9% | 0.00% | – |
| Q4 2020 | $135,000 | +35.0% | 54,494 | +33.8% | 0.00% | – |
| Q3 2020 | $100,000 | -34.6% | 40,742 | -5.7% | 0.00% | – |
| Q2 2020 | $153,000 | +86.6% | 43,224 | +23.3% | 0.00% | – |
| Q1 2020 | $82,000 | +1.2% | 35,064 | -4.8% | 0.00% | – |
| Q4 2019 | $81,000 | +20.9% | 36,841 | 0.0% | 0.00% | – |
| Q3 2019 | $67,000 | +19.6% | 36,841 | -5.0% | 0.00% | – |
| Q2 2019 | $56,000 | -52.1% | 38,762 | -34.9% | 0.00% | – |
| Q1 2019 | $117,000 | +28.6% | 59,540 | -14.1% | 0.00% | – |
| Q4 2018 | $91,000 | -66.0% | 69,308 | -36.4% | 0.00% | – |
| Q3 2018 | $268,000 | +262.2% | 108,956 | +397.5% | 0.00% | – |
| Q2 2018 | $74,000 | +32.1% | 21,899 | +64.9% | 0.00% | – |
| Q1 2018 | $56,000 | – | 13,284 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEDBUSH SECURITIES INC | 277,177 | $915,000 | 0.11% |
| WEBSTER BANK, N. A. | 50,000 | $165,000 | 0.02% |
| Brown Advisory Securities, LLC | 28,000 | $92,000 | 0.02% |
| SIMPLEX TRADING, LLC | 50,804 | $167,000 | 0.01% |
| GOFEN & GLOSSBERG LLC /IL/ | 25,000 | $83,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 89,372 | $295,000 | 0.00% |
| Squarepoint Ops LLC | 10,194 | $34,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,851 | $6,000 | 0.00% |
| WOLVERINE TRADING, LLC | 58,500 | $193,000 | 0.00% |
| WOLVERINE TRADING, LLC | 61,690 | $204,000 | 0.00% |